## Abstract The cytolytic activity of lymphokine‐activated killer (LAK) cells against human neuroblastoma (NB) cells was investigated using the continuous NB cell lines, IMR‐32, Kelly, and two subclones of SK‐N‐SH, SH‐SY5Y (neuroblastic phenotype), and SH‐EP (non‐neuronal phenotype). NB cells were
Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines
✍ Scribed by Ming-Hai Wang; Hans-Dieter Flad; Andreas Böhle; Yi-Qing Chen; Artur J. Ulmer
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 469 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0165-2478
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The antibody-dependent cellular cytotoxicity (ADCC) properties of a murine monoclonal antibody (MAb), designated D6l2 (lgG,J, which reacts with human colon carcinomas, was studied using normal human peripheral blood lymphocytes (PBMNC). Although the level of ADCC of PBMNC with D612 varied among diff
Lymphokine-activated killer activity and natural killer activity in hepatocellular carcinoma patients were d. Maximum lymphokine-activated killer activity was induced at 3 to 6 days of incubation, and lymphokine-activated killer activity tended to increase in a manner dose dependent of recombinant i
## Abstract Results concerning a possible link between susceptibility to natural‐cell‐mediated immune cytolysis and the multi‐drug resistance (MDR) phenotype are conflicting. We evaluated in human acute lymphocytic leukemia the relationship between acquired drug resistance and susceptibility to cyt